| PERIOD ENDING | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 11,525 | 6,131 | | Cost of Revenue | 6,303 | 2,925 | | | Gross Profit | 5,222 | 3,205 | | | Operating Expenses | | Research Development | 60 | 68 | | Selling General and Administrative | 4,210 | 2,116 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 952 | 1,022 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 592 | 18 | | Earnings Before Interest And Taxes | 1,548 | 1,040 | | Interest Expense | 5,315 | 2 | | Income Before Tax | (3,767) | 1,039 | | Income Tax Expense |
-
|
-
| | Minority Interest | 4 |
-
| | | | Net Income From Continuing Ops | (3,767) | 1,039 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (3,767) | 1,039 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($3,767) | $1,039 |
|
0.22% Nasdaq 
Income Statement
